Illumina ramped up its US lobbying spend in Washington, DC, in recent months, hiring law firms Sidley Austin and DLA Piper to advocate for the biotechnology company as it prepares to contest a Federal Trade Commission (FTC) antitrust complaint at trial in August, according to Reuters.
The FTC’s administrative complaint, filed in March, said San Diego-based Illumina’s proposed US$7.1 billion acquisition of GRAIL would harm innovation in the market for “multi-cancer early detection” tests and drive up prices. GRAIL, which makes a non-invasive biopsy test, and its competitors rely on Illumina technology, the agency stated.
Companies facing regulatory or enforcement scrutiny often boost outside advocacy efforts. Illumina spent US$360,000 on US lobbying in the second quarter, including US$150,000 for Sidley Austin government affairs services and US$40,000 for DLA Piper, which was hired in July. The firms stated in disclosures they were lobbying in Congress to support Illumina’s acquisition of GRAIL.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Chamber of Commerce Sues to Overturn FTC Non-Compete Ban
Apr 24, 2024 by
CPI
FTC Chief Warns of Healthcare Price Fixing Risks Amid Tech Advancements
Apr 24, 2024 by
CPI
Amazon’s Investment in Anthropic Faces Antitrust Scrutiny
Apr 24, 2024 by
CPI
Italian Antitrust Authority Fines Amazon €10 Million for Unfair Trade Practices
Apr 24, 2024 by
CPI
Tuta Mail Raises Alarm Over Google Search Ranking Plunge Amidst DMA Rollout
Apr 24, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI